A major advance in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This vital tumor suppressor protein is frequently inactivated in several kinds of malignancies, resulting https://bookmark-share.com/story22022155/vhh-fragments-restore-the-p53-protein-the-potential-pathway-for-malignant-therapy